The list of major shareholders of Lepu might be valuable in...

The list of major shareholders of Lepu might be valuable in asssessing whether it has the ability to speed up bringing Cavatak to market and reaching your $5.00 target...

	Column 1
0	Column 1 0 Business Summary

Manufactures and distributes medical devicesLepu Medical Technology (Beijing) Co. Ltd. engages in the research, development, production, and sale of medical equipment and accessories.Its products include medical equipment such as stent systems, occluders, interventional cardiology products, including rapamycin-eluting stents, percutaneous transluminal coronary angioplasty (PTCA) balloon dilatation catheters, guide wires and radial artery compression tourniquets; occlusion devices, including ductus arteriosus occlusion devices, ventricular septal defect occlusion devices and atrial septal defect occlusion devices, among others; anesthetic products, including blood pressure transducers, central venous catheters and infusion pumps; general medical care products, including blood sampling kits, needle-free connectors and accessories, as well as medical equipment and peripheral vascular interventional products.The company was founded on June 11, 1999 and is headquartered Beijing, China.Number of employees : 5 465 persons.[/table]

	Column 1
0	Column 1 0 Sales per Businesses

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8	Column 9	Column 10	Column 11	Column 12	Column 13	Column 14	Column 15	Column 16	Column 17	Column 18	Column 19	Column 20	Column 21	Column 22	Column 23	Column 24	Column 25	Column 26	Column 27	Column 28	Column 29	Column 30	Column 31	Column 32	Column 33	Column 34	Column 35	Column 36	Column 37	Column 38	Column 39	Column 40	Column 41	Column 42	Column 43	Column 44	Column 45	Column 46	Column 47	Column 48	Column 49	Column 50	Column 51	Column 52
0	{colgroup}{col=40%x@}{/col}{col=15%x@}{/col}{col=10%x@}{/col}{col=15%x@}{/col}{col=10%x@}{/col}{col=10%x@}{/col}{/colgroup}	2015	2016	DeltaCNY (in Million)	%	CNY (in Million)	%Support System	819.47	29.9%	964.92	28.2%	+17.75%Other	712.65	26%	869.16	25.4%	+21.96%Pharmaceutical Raw Materials	509.12	18.6%	408.42	11.9%	-19.78%Clopidogrel Hydrogen Sulfate	198.01	7.2%	441.78	12.9%	+123.11%Pacemaker	169.13	6.2%	169.01	4.9%	-0.07%In Vitro Diagnostic Reagents & Equipment	136.12	5%	206.71	6%	+51.85%Occluder Device	100.71	3.7%	101.82	3%	+1.1%Atorvastatin Calcium	62.54	2.3%	167.13	4.9%	+167.23%Surgical Equipment Product	60.95	2.2%	138.80	4.1%	+127.72%

[/table]

	Column 1
0	Column 1 0 Managers

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8	Column 9	Column 10	Column 11	Column 12	Column 13	Column 14	Column 15	Column 16	Column 17	Column 18	Column 19	Column 20	Column 21	Column 22	Column 23	Column 24	Column 25	Column 26	Column 27	Column 28	Column 29	Column 30	Column 31	Column 32	Column 33	Column 34
0	{colgroup}{col=30%x@}{/col}{col=7%x@}{/col}{col=13%x@}{/col}{col=50%x@}{/col}{/colgroup}Name	Age	Since	TitleZhong Jie Pu, PhD	54	-	Chairman & General ManagerGuo Qiang Li, MBA	62	2014	Chairman-Supervisory BoardYong Wang	44	2007	Chief Financial Officer & Deputy General ManagerYu Pu Ma	55	-	Vice ChairmanYang Xu	50	-	DirectorMeng Xu	49	-	Independent DirectorLi Jia Fu	54	-	Independent DirectorLei Lin	49	-	DirectorLei Chen	47	2014	Independent DirectorWu Yi Guo	59	-	Member-Supervisory Board

[/table]

	Column 1	Column 2
0	Column 1 0 Equities

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8	Column 9	Column 10	Column 11	Column 12	Column 13
0	{colgroup}{col=10%x@}{/col}{col=8%x@}{/col}{col=17%x@}{/col}{col=17%x@}{/col}{col=9%x@}{/col}{col=17%x@}{/col}{col=9%x@}{/col}{col=13%x@}{/col}{/colgroup}	Vote	Quantity	Float	Company-owned shares	Total FloatShare A	1	1,781,652,921	503,131,362	28.2%		0.0%	28.2%

[/table]

	Column 1	Column 2
0	Column 1 0 Shareholders

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8	Column 9	Column 10	Column 11	Column 12	Column 13	Column 14	Column 15	Column 16	Column 17	Column 18	Column 19	Column 20	Column 21	Column 22	Column 23
0	{colgroup}{col=65%x@}{/col}{col=20%x@}{/col}{col=15%x@}{/col}{/colgroup}Name	Equities	%China State-Owned Assets Supervision & Admn Commission	396,243,877	28.0%Zhong Jie Pu, PhD	199,922,336	14.1%China Universal Asset Management Co., Ltd.	74,428,154	5.26%ICBC Credit Suisse Asset Management Co., Ltd.	34,712,422	2.46%WP Medical Technologies, Inc.	30,992,150	2.19%Yinhua Fund Management Co., Ltd.	23,650,725	1.67%Penghua Fund Management Co., Ltd.	22,378,080	1.58%Qing Chuan Xiong	19,283,149	1.36%China Asset Management Co., Ltd.	18,544,610	1.31%Fullgoal Fund Management Co., Ltd.	12,533,215	0.89%

[/table]

	Column 1
0	Column 1 0 Company contact information

Lepu Medical Technology (Beijing) Co., Ltd.No. 37 Chaoqian RoadChangping DistrictBeijing 102200Phone : +86.10.8012.0622Fax : +86.10.8012.0776Web : www.lepumedical.com[/table]